Skip to main content
All lobbying clients

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

Lobbying client · New York · filed 2025 to 2026

A clinical biopharmaceutical company developing products to treat brain health disorders.

$1,170,000 Reported spend
15 Filings counted
1 Outside firm hired
0 Bills named

Spend is reported income plus in-house expenses across 15 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $560,000 6 filings
  • 2025 $610,000 9 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
  • Health & Human Services, Dept of (HHS) 2
  • Veterans Affairs, Dept of (VA) 2
 Recent filings 15 total
Q3 report
THE CONAFAY GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View → Q3 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $130,000 expenses · posted Oct 13, 2026
View → Q2 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 expenses · posted Jul 20, 2026
View → Q2 report
THE CONAFAY GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View → Q1 report
THE CONAFAY GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View → Q1 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $100,000 expenses · posted Apr 15, 2026
View → Q4 report
THE CONAFAY GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View → Q4 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 expenses · posted Jan 20, 2026
View → Q3 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $90,000 expenses · posted Oct 20, 2025
View → Q3 report
THE CONAFAY GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025
View → Q2 report
THE CONAFAY GROUP, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 18, 2025
View → Q2 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $90,000 expenses · posted Jul 18, 2025
View → Q1 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $100,000 expenses · posted Apr 21, 2025
View → Q1 report
THE CONAFAY GROUP, LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 18, 2025
View → Registration
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 16, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem